I've been away for a couple of weeks and look what's happened to the sp. Today's announcement won't stir the market if recent history is anything to go by.
What I got out of this was 1) BLT is funding the Oculopharyngeal muscular dystrophy program but I haven't seen any statement about the affect on cash flow and therefore next capital raising date, and 2) despite the good work already done in China and Queensland, the pain program seems to have slipped by nine months.
I hope the one juicy para in the chairman's address was a real signal of something it the wind. This presentation did say that responses from big pharma would been sought and evaluated this month. If there is some substance to this then we may well have a very good Christmas.
BLT Price at posting:
40.0¢ Sentiment: LT Buy Disclosure: Held
